Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia ...Middle East

Egret Therapeutics, a portfolio company of Turret Capital Management, announces FDA Clearance of its IND Application for EGT 101 NEW YORK, Feb. 4, 2023 /PRNewswire/ -- Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for...

Hence then, the article about egret therapeutics receives fda clearance of ind application for egt 101 for treatment of delayed cerebral ischemia was published today ( Saturday 04/02/2023 - 11:16 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia )

Also on site :

• 11 Colorado schools receive threats, several on lockdown
• Aurora man arrested on suspicion of starting massive Leetsdale Drive fire
• US Visa Processing Frozen By Trump Administration in 75 Countries